Sigma Healthcare (ASX:SIG) logged AU$0.064 in normalized EPS for fiscal 2026, compared with AU$0.052 a year ago, a Thursday filing showed.
Analysts polled by FactSet expected AU$0.0654.
For the 12 months ended June 30, sales revenue from ordinary activities was AU$10.83 billion versus AU$6 billion previously, the Australia-listed pharmaceutical wholesaler and distributor added. Analysts surveyed by FactSet projected AU$10.82 billion.
The board declared a final dividend of AU$0.02 per security, up from AU$0.013 a year earlier, payable Sept. 22 to shareholders as of Sept. 4.
The company expects double digit like-for-like sales growth for the Australian CW-branded store network in fiscal 2027.
The company's shares were down nearly 5% in recent Thursday trade.